Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.17.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.17.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.562ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.562ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.562ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.562NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.219ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.219ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.219ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.219NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
XAORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AZ.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AZ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.114ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.114ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.114ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.114NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used